Prostate Cancer Imaging

Chapter
Part of the Atlas of Oncology Imaging book series (AOI, volume 1)

Abstract

The prostate is an exocrine gland that is part of the male reproductive system. It is located in the pelvis, just below the urinary bladder and anterior to the rectum surrounding the prostatic segment of the urethra. Its shape is described as an “inverted pyramid,” with the widest portion situated cranially (prostatic base) and its narrowest portion caudally (prostatic apex). Between the prostatic base and apex lies the “midgland.” Its function is to contribute to semen production, together with the seminal vesicles and testes, and it also plays a role in male ejaculation.

Keywords

Pyramid 

References

  1. 1.
    Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011. CA: Cancer J Clin. 2011;61:212–36.CrossRefGoogle Scholar
  2. 2.
    McNeal JE, Redwine EA, Freiha FS, Stamey TA. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol. 1988;12:897–906.PubMedCrossRefGoogle Scholar
  3. 3.
    Edge SB, Byrd DR, Compton CC. American Joint Committee on Cancer: AJCC cancer staging manual. New York: Springer; 2010.Google Scholar
  4. 4.
    Beyersdorff D, Taupitz M, Winkelmann B, et al. Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging. Radiology. 2002;224:701–6.PubMedCrossRefGoogle Scholar
  5. 5.
    Shukla Dave A, Hricak H, Moskowitz C, et al. Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines. Radiology. 2007;245:499–506.PubMedCrossRefGoogle Scholar
  6. 6.
    Rosenkrantz A, Kopec M, Kong X, et al. Prostate cancer vs. post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging. J Magn Reson Imaging. 2010;31:1387–94.PubMedCrossRefGoogle Scholar
  7. 7.
    Akin O, Sala E, Moskowitz CS, et al. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology. 2006;239:784–92.PubMedCrossRefGoogle Scholar
  8. 8.
    Bloch BN, Furman Haran E, Helbich T, et al. Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging—initial results. Radiology. 2007;245:176–85.PubMedCrossRefGoogle Scholar
  9. 9.
    Wang L, Hricak H, Kattan MW, et al. Prediction of seminal vesicle invasion in prostate cancer: incremental value of adding endorectal MR imaging to the Kattan nomogram. Radiology. 2007;242:182–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Lawrentschuk N, Klotz L. Active surveillance for low-risk prostate cancer: an update. Nat Rev Urol. 2011;8:312–20.PubMedCrossRefGoogle Scholar
  11. 11.
    Vargas HA, Wassberg C, Akin O, Hricak H. Magnetic resonance imaging of the treated prostate. Radiology. 2012;262:26–42.PubMedCrossRefGoogle Scholar
  12. 12.
    Westphalen A, McKenna D, Kurhanewicz J, Coakley F. Role of magnetic resonance imaging and magnetic resonance spectroscopic imaging before and after radiotherapy for prostate cancer. J Endourol. 2008;22:789–94.PubMedCrossRefGoogle Scholar
  13. 13.
    Akin O, Gultekin DH, Vargas HA, et al. Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: preliminary results. Eur Radiol. 2011;21:1970–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Hebert Alberto Vargas
    • 1
  • Joshua Chaim
    • 1
  • Oguz Akin
    • 1
  1. 1.Department of RadiologyMemorial Sloan-Kettering Cancer CenterNew YorkUSA

Personalised recommendations